Laminar Pharma

Palma de Mallorca, Spain · Founded 2006 · Privately Held (backing)

Operator of a biopharmaceutical company intended to focus on the discovery of membrane-lipid therapy-based drugs. Laminar Pharma is based in Palma de Mallorca, Spain and was founded in 2006. Its last known valuation is $168 million. It has raised $46 million.

Last price · $/share
—
Implied valuation
$168.0M
Total raised
$46.0M
Last round
—
No prints on record

No secondary trades in Laminar Pharma shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Laminar Pharma with a free account
  • ·Watch Laminar Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Laminar Pharma prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Laminar Pharma stock.